Cargando…
Methylation-Induced Silencing of ALDH2 Facilitates Lung Adenocarcinoma Bone Metastasis by Activating the MAPK Pathway
Bone metastasis (BM) dramatically reduces the quality of life and life expectancy in lung adenocarcinoma (LUAD) patients. There is an urgent need to identify potential biomarkers for application in the treatment of this deadly disease. We compared patient BM, LUAD, and para-LUAD tissues using proteo...
Autores principales: | Yang, Mengdi, Wang, AiTing, Li, Changcan, Sun, Jing, Yi, Gang, Cheng, Hao, Liu, Xueni, Wang, Zhiyu, Zhou, Yiyi, Yao, Guangyu, Wang, Shuai, Liang, Rui, Li, Bin, Li, Dan, Zhao, Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7406638/ https://www.ncbi.nlm.nih.gov/pubmed/32850324 http://dx.doi.org/10.3389/fonc.2020.01141 |
Ejemplares similares
-
Differentially expressed and survival‐related proteins of lung adenocarcinoma with bone metastasis
por: Yang, Mengdi, et al.
Publicado: (2018) -
Value of combining PET/CT and clinicopathological features in predicting EGFR mutation in Lung Adenocarcinoma with Bone Metastasis
por: Yao, Guangyu, et al.
Publicado: (2020) -
A Retrospective Study of predicting risk of Metastasis among FDG-avid Bone Lesions in (18)F-FDG PET/CT
por: Yao, Guangyu, et al.
Publicado: (2020) -
ALDH3A1 driving tumor metastasis is mediated by p53/BAG1 in lung adenocarcinoma
por: Fan, Feifei, et al.
Publicado: (2021) -
TOX Acts as a Tumor Suppressor by Inhibiting mTOR Signaling in Colorectal Cancer
por: Yang, Mengdi, et al.
Publicado: (2021)